Aurinia Pharmaceuticals Inc. (AUPH)

NASDAQ: AUPH · Real-Time Price · USD

16.65

-0.56 (-3.25%)

At close: Oct 30, 2026, 4:00 PM EDT

16.66

+0.01 (0.07%)

After-hours: Oct 30, 2026, 7:24 PM EDT

Aurinia Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	46.15	80.16	83.4	48.76	94.09	231.64
Short-Term Investments	440.74	317.78	275.04	301.61	295.22	234.18
Cash & Short-Term Investments	486.88	397.94	358.44	350.37	389.31	465.82
Cash Growth	38.51%	11.02%	2.30%	-10.00%	-16.43%	16.94%
Accounts Receivable	47.41	41.45	36.54	24.09	13.48	15.41
Other Receivables	-	0.7	0.6	0.7	1.1	-
Receivables	47.41	42.15	37.14	24.79	14.58	15.41
Inventory	43.73	45.69	39.23	39.71	24.75	19.33
Prepaid Expenses	5.92	5.75	11.22	9.49	13.58	11.71
Restricted Cash	-	0.05	0.04	0.12	0.08	0.26
Other Current Assets	3.95	0.38	0.53	0.33	0.23	0.8
Total Current Assets	587.89	491.97	446.6	424.8	442.54	513.32
Property, Plant & Equipment	63.9	79.57	98.87	116.57	8.56	9.8
Long-Term Investments	-	-	-	0.2	-	-
Other Intangible Assets	3.17	3.76	4.36	4.98	6.43	8.4
Long-Term Deferred Tax Assets	170.65	176.19	-	-	-	-
Other Long-Term Assets	0.09	0.09	0.82	1.52	13.34	11.84
Total Assets	825.7	751.59	550.65	548.06	470.86	543.37

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.01	3.31	5.19	4.33	3.09	3.88
Accrued Expenses	63.3	66.47	54.12	50.06	36.28	30.25
Current Portion of Leases	17.96	17.59	15.07	15.6	0.94	1.06
Current Income Taxes Payable	-	-	-	-	0.63	0.81
Current Unearned Revenue	10.41	3.72	11	4.81	3.15	0.19
Other Current Liabilities	1.32	2.63	12.39	2.39	2.03	4.45
Total Current Liabilities	96.01	93.72	97.76	77.19	46.11	40.65
Long-Term Leases	40.71	57.22	64.3	82.01	7.15	7.68
Long-Term Unearned Revenue	7.16	12.65	1.7	-	-	-
Other Long-Term Liabilities	1.19	6.66	9.41	10.91	12.17	15.95
Total Liabilities	168.19	170.26	173.17	170.11	65.43	64.28

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	1,128	1,120	1,188	1,200	1,185	1,177
Additional Paid-In Capital	77.04	111.26	127	120.79	85.49	59.01
Retained Earnings	-545.9	-649.37	-936.57	-942.32	-864.3	-756.12
Comprehensive Income & Other	-1.13	-0.6	-0.65	-0.73	-1.06	-0.85
Shareholders' Equity	657.52	581.33	377.48	377.95	405.44	479.09
Total Liabilities & Equity	825.7	751.59	550.65	548.06	470.86	543.37

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	58.66	74.81	79.37	97.61	8.09	8.74
Net Cash (Debt)	428.22	323.13	279.07	252.76	381.22	457.08
Net Cash Growth	56.69%	15.79%	10.41%	-33.70%	-16.60%	17.22%
Net Cash Per Share	3.15	2.33	1.91	1.76	2.69	3.53
Filing Date Shares Outstanding	134	132.97	137.34	144.62	142.58	141.65
Total Common Shares Outstanding	134	132.32	140.88	143.83	142.27	141.6
Working Capital	491.88	398.24	348.83	347.61	396.43	472.68
Book Value Per Share	4.91	4.39	2.68	2.63	2.85	3.38
Tangible Book Value	654.35	577.57	373.12	372.98	399.01	470.69
Tangible Book Value Per Share	4.88	4.36	2.65	2.59	2.80	3.32
Machinery	-	2.02	2.02	2.02	1.87	1.88
Construction In Progress	-	-	-	-	0.26	0.39
Leasehold Improvements	-	3.24	3.24	3.24	2.98	2.98

SEC Filings: 10-K · 10-Q